{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:38Z","timestamp":1791194018368,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":110,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA09236"],"award-info":[{"award-number":["DA09236"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["DA027755"],"award-info":[{"award-number":["DA027755"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medicinova"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1111\/adb.12261","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T05:18:32Z","timestamp":1431667112000},"page":"895-903","source":"Crossref","is-referenced-by-count":95,"title":["The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers"],"prefix":"10.1111","volume":"21","author":[{"given":"Ziva D.","family":"Cooper","sequence":"first","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk W.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Pavlicova","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Mailman School of Public Health; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Glass","sequence":"additional","affiliation":[{"name":"Division of Biostatistics; New York State Psychiatric Institute; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K.","family":"Vosburg","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Manubay","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Martinez","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jermaine D.","family":"Jones","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A.","family":"Saccone","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Comer","sequence":"additional","affiliation":[{"name":"Division on Substance Abuse; New York Psychiatric Institute; Department of Psychiatry; College of Physicians and Surgeons; Columbia University; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"10.1111\/adb.12261-BIB0001|adb12261-cit-0001","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1111\/adb.12261-BIB0002|adb12261-cit-0002","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.0b013e3181d7d651","article-title":"MN166-001 investigators. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?","volume":"74","author":"Barkhof","year":"2010","journal-title":"Neurology"},{"key":"10.1111\/adb.12261-BIB0003|adb12261-cit-0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J Addict Dis"},{"key":"10.1111\/adb.12261-BIB0004|adb12261-cit-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-420118-7.00001-9","article-title":"Glial modulators as potential treatment of psychostimulant abuse","volume":"69","author":"Beardsley","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1111\/adb.12261-BIB0005|adb12261-cit-0005","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1471-4159.1993.tb09814.x","article-title":"Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area","volume":"61","author":"Beitner-Johnson","year":"1993","journal-title":"J Neurochem"},{"key":"10.1111\/adb.12261-BIB0007|adb12261-cit-0007","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbi.2009.01.014","article-title":"The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release","volume":"23","author":"Bland","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1111\/adb.12261-BIB0008|adb12261-cit-0008","first-page":"298","article-title":"Inflammatory cytokines in nonpathological states","volume":"15","author":"Cannon","year":"2000","journal-title":"News Physiol Sci"},{"key":"10.1111\/adb.12261-BIB0010|adb12261-cit-0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.12.018","article-title":"Abuse liability of oxycodone as a function of pain and drug use history","volume":"109","author":"Comer","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12261-BIB0011|adb12261-cit-0011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/FBP.0b013e3283536d6f","article-title":"Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers","volume":"23","author":"Cooper","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1111\/adb.12261-BIB0012|adb12261-cit-0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2005.04.002","article-title":"The alpha2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration","volume":"383","author":"Garrido","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1111\/adb.12261-BIB0013|adb12261-cit-0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2006.02.053","article-title":"The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family","volume":"538","author":"Gibson","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/adb.12261-BIB0014|adb12261-cit-0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(78)92823-4","article-title":"Clonidine blocks acute opiate-withdrawal symptoms","volume":"2","author":"Gold","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/adb.12261-BIB0015|adb12261-cit-0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.136.1.100","article-title":"Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal","volume":"136","author":"Gold","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1111\/adb.12261-BIB0016|adb12261-cit-0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0376-8716(80)90323-3","article-title":"Efficacy of clonidine in opiate withdrawal: a study of thirty patients","volume":"6","author":"Gold","year":"1980","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12261-BIB0017|adb12261-cit-0017","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0376-8716(81)90040-5","article-title":"Opiate detoxification with lofexidine","volume":"8","author":"Gold","year":"1981","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1111\/adb.12261-BIB0018|adb12261-cit-0018","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002024","article-title":"Alpha2 adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/adb.12261-BIB0019|adb12261-cit-0019","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1111\/adb.12261-BIB0020|adb12261-cit-0020","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbi.2008.05.004","article-title":"Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1111\/adb.12261-BIB0021|adb12261-cit-0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbi.2008.09.012","article-title":"Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)","volume":"23","author":"Hutchinson","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1111\/adb.12261-BIB0022|adb12261-cit-0022","first-page":"197","volume-title":"Handbook of Experimental Pharmacology","volume":"45","author":"Jasinski","year":"1977"},{"key":"10.1111\/adb.12261-BIB0023|adb12261-cit-0023","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archpsyc.1985.01790340041006","article-title":"Clonidine in morphine withdrawal. Differential effects on signs and symptoms","volume":"42","author":"Jasinski","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/adb.12261-BIB0024|adb12261-cit-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/cli.14.8","article-title":"Ibudilast for the treatment of drug addiction and other neurological conditions","volume":"4","author":"Johnson","year":"2014","journal-title":"Clin Investig (Lond)"},{"key":"10.1111\/adb.12261-BIB0025|adb12261-cit-0025","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.1850-04.2004","article-title":"A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine","volume":"24","author":"Johnston","year":"2004","journal-title":"J Neurosci"},{"key":"10.1111\/adb.12261-BIB0026|adb12261-cit-0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/adb.12261-BIB0027|adb12261-cit-0027","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: interactions and clinical management","volume":"19","author":"Lintzeriz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1111\/adb.12261-BIB0028|adb12261-cit-0028","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.bbi.2011.03.016","article-title":"Naloxone-precipitated morphine withdrawal behavior and brain IL-1\u03b2 expression: comparison of different mouse strains","volume":"25","author":"Liu","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1111\/adb.12261-BIB0029|adb12261-cit-0029","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addiction-a clinical perspective","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/adb.12261-BIB0031|adb12261-cit-0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","volume":"108","author":"Meader","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/adb.12261-BIB0032|adb12261-cit-0032","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/sj.npp.1301007","article-title":"Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse","volume":"31","author":"Narita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/adb.12261-BIB0033|adb12261-cit-0033","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/npp.2008.127","article-title":"Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys","volume":"34","author":"Negus","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/adb.12261-BIB1001|adb12261-cit-1001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-801284-0.00012-9","article-title":"Opportunities for the development of neuroimmune therapies in addiction","volume":"118","author":"Ray","year":"2014","journal-title":"Int Rev Neurobiol"},{"key":"10.1111\/adb.12261-BIB0034|adb12261-cit-0034","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2125.2008.03270.x","article-title":"Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses","volume":"66","author":"Rolan","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/adb.12261-BIB0035|adb12261-cit-0035","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1517\/14656560903426189","article-title":"Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease","volume":"10","author":"Rolan","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/adb.12261-BIB0036|adb12261-cit-0036","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1592\/phco.27.8.1111","article-title":"Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study","volume":"27","author":"Schroeder","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1111\/adb.12261-BIB0037|adb12261-cit-0037","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/adb.12261-BIB0039|adb12261-cit-0039","unstructured":"Substance Abuse and Mental Health Services Administration 2013 Results from the 2012 National Survey of Substance Abuse Treatment Services: data on substance abuse treatment facilities"},{"key":"10.1111\/adb.12261-BIB0040|adb12261-cit-0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000058654","article-title":"Structural biology of cytokines, their receptors, and signaling complexes: implications for the immune and neuroendocrine circuit","volume":"69","author":"Walter","year":"1997","journal-title":"Chem Immunol"},{"key":"10.1111\/adb.12261-BIB0041|adb12261-cit-0041","first-page":"253","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Drugs"},{"key":"10.1111\/adb.12261-BIB0042|adb12261-cit-0042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.04.002","article-title":"A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal","volume":"97","author":"Yu","year":"2008","journal-title":"Drug Alcohol Depend"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadb.12261","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/adb.12261\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:22:39Z","timestamp":1625311359000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/adb.12261"}},"subtitle":["Ibudilast decreases withdrawal"],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.1111\/adb.12261","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}